Pregnenolone can protect the brain from cannabis intoxication

Science

Volumn 343, Issue 6166, 2014, Pages 94-98

  Vallée, Monique ^a,b   Vitiello, Sergio ^a,b   Bellocchio, Luigi ^a,b   Heb́ert Chatelain, Etienne ^a,b   Monlezun, Stéphanie ^c   Martin Garcia, Elena ^d   Kasanetz, Fernando ^a,b   Baillie, Gemma L ^e,g   Panin, Francesca ^a,b   Cathala, Adeline ^a,b   Roullot Lacarrière, Valérie ^a,b   Fabre, Sandy ^c   Hurst, Dow P ^f   Lynch, Diane L ^f   Shore, Derek M ^f   Deroche Gamonet, Véronique ^a,b   Spampinato, Umberto ^a,b   Revest, Jean Michel ^a,b   Maldonado, Rafael ^d   Reggio, Patricia H ^f   Ross, Ruth A ^e,g   Marsicano, Giovanni ^a,b   Piazza, Pier Vincenzo ^a,b   more..

^a INSTITUT FRANÇOIS MAGENDIE   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c Alienor Farma Parc Scientifique Unitec1 2 Allée du Doyen Georges Brus ^*  (France)

^d UNIVERSITAT POMPEU FABRA   (Spain)

^e UNIVERSITY OF ABERDEEN   (United Kingdom)

^f UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

^g UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; CANNABIS; PREGNENOLONE; SEPRANOLONE; TESTOSTERONE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; DRONABINOL;

BIOCHEMISTRY; BRAIN; DICOTYLEDON; DISEASE TREATMENT; DRUG USER; FUNCTIONAL ROLE; HORMONE; INHIBITOR; PHYSIOLOGY; SIGNALING; STEROID; TOXIC SUBSTANCE;

ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN PROTECTION; CANNABIS ADDICTION; CONTROLLED STUDY; CORPUS STRIATUM; LOCOMOTION; MEMORY CONSOLIDATION; MEMORY DISORDER; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; TISSUE LEVEL; ANIMAL; BRAIN; C57BL MOUSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; MALE; METABOLISM; SPRAGUE DAWLEY RAT; WISTAR RAT;

ANIMALS; BRAIN; CANNABINOID RECEPTOR ANTAGONISTS; CANNABIS; DRONABINOL; MALE; MARIJUANA ABUSE; MICE; MICE, INBRED C57BL; PREGNENOLONE; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1;

EID: 84892749496     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1243985     Document Type: Article

References (36)

1. P. V. Piazza, M. Le Moal, Brain Res. Brain Res. Rev. 25, 359-372 (1997).
2. E. R. de Kloet, M. Joëls, F. Holsboer, Nat. Rev. Neurosci. 6, 463-475 (2005).
3. B. S. McEwen, P. J. Gianaros, Annu. Rev. Med. 62, 431-445 (2011).
4. C. Sandi, Nat. Rev. Neurosci. 5, 917-930 (2004).
5. E. E. Baulieu, P. Robel, M. Schumacher, Int. Rev. Neurobiol. 46, 1-32 (2001).
6. P. Porcu et al., Steroids 74, 463-473 (2009).
7. M. Vallée, W. Mayo, G. F. Koob, M. Le Moal, Int. Rev. Neurobiol. 46, 273-320 (2001).
8. N. Krone et al., J. Steroid Biochem. Mol. Biol. 121, 496-504 (2010).
9. Materials and methods and supporting data are available in the supplementary materials on Science Online.
10. Y. Gaoni, R. Mechoulam, J. Am. Chem. Soc. 86, 1646-1647 (1964).
11. G. Marsicano, B. Lutz, J. Endocrinol. Invest. 29, 27-46 (2006).
12. D. Piomelli, Nat. Rev. Neurosci. 4, 873-884 (2003).
13. K. Mackie, N. Stella, Am. Assoc. Pharm. Sci. J. 8, E298-E306 (2006).
14. A. C. Howlett et al., Pharmacol. Rev. 54, 161-202 (2002).
15. K. Monory et al., PLOS Biol. 5, e269 (2007).
16. P. R. Manna et al., J. Biol. Chem. 288, 8505-8518 (2013).
17. D. M. Stocco, X. Wang, Y. Jo, P. R. Manna, Mol. Endocrinol. 19, 2647-2659 (2005).
18. A. B. Foster, M. Jarman, C. S. Leung, M. G. Rowlands, G. N. Taylor, J. Med. Chem. 26, 50-54 (1983).
19. I. Greenberg, J. Kuehnle, J. H. Mendelson, J. G. Bernstein, Psychopharmacology (Berl.) 49, 79-84 (1976).
20. T. C. Kirkham, Behav. Pharmacol. 16, 297-313 (2005).
21. T. Lundqvist, Pharmacol. Biochem. Behav. 81, 319-330 (2005).
22. L. Bellocchio et al., Nat. Neurosci. 13, 281-283 (2010).
23. C. M. Williams, P. J. Rogers, T. C. Kirkham, Physiol. Behav. 65, 343-346 (1998).
24. E. Puighermanal et al., Neuropsychopharmcology 38, 1334-1343 (2013).
25. M. Kano, T. Ohno-Shosaku, Y. Hashimotodani, M. Uchigashima, M. Watanabe, Physiol. Rev. 89, 309-380 (2009).
26. G. Di Chiara, V. Bassareo, Curr. Opin. Pharmacol. 7, 69-76 (2007).
27. G. Bénard et al., Nat. Neurosci. 15, 558-564 (2012).
28. K. H. Ahn, M. M. Mahmoud, D. A. Kendall, J. Biol. Chem. 287, 12070-12082 (2012).
29. G. L. Baillie et al., Mol. Pharmacol. 83, 322-338 (2013).
30. M. Clark, F. Guarnieri, I. Shkurko, J. Wiseman, J. Chem. Inf. Model. 46, 231-242 (2006).
31. L. T. May, K. Leach, P. M. Sexton, A. Christopoulos, Annu. Rev. Pharmacol. Toxicol. 47, 1-51 (2007).
32. T. P. Kenakin, Br. J. Pharmacol. 165, 1659-1669 (2012).
33. R. Maldonado, O. Valverde, F. Berrendero, Trends Neurosci. 29, 225-232 (2006).
34. R. A. Ross, Trends Pharmacol. Sci. 28, 567-572 (2007).
35. A. Christopoulos, T. Kenakin, Pharmacol. Rev. 54, 323-374 (2002).
36. F. A. Pamplona et al., Proc. Natl. Acad. Sci. U.S.A. 109, 21134-21139 (2012).